Clinical trial
The Impact of Magnesium Oxide Monohydrate Compared to Placebo on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients
NCT03840226 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Magnesium Oxide Monohydrate Compared to Placebo on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients
- Lead sponsor
- Sheba Medical Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 25, 2019
- Completion date
- March 1, 2026
- Enrollment
- 320 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.